Fulcrum Therapeutics, Inc. (FULC)
USD 4.23
(-6.83%)
USD 4.23
(-6.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -90.96 Million | -97.05 Million | -78.47 Million | -53.65 Million | -39.48 Million | -22.56 Million |
| Net Income | -97.33 Million | -109.87 Million | -80.84 Million | -70.81 Million | -82.67 Million | -32.58 Million |
| Depreciation & Amortization | 2.17 Million | 2.41 Million | 2.51 Million | 2.37 Million | 2.05 Million | 1.34 Million |
| Deferred income taxes | -20.3 Million | - | - | 1.93 Million | - | - |
| Stock-based compensation | 14.8 Million | 13.35 Million | 11.07 Million | 7.35 Million | 4.22 Million | 2.15 Million |
| Change in working capital | -4.61 Million | -3.09 Million | -11.88 Million | 7.5 Million | 11.32 Million | 6.52 Million |
| Other non-cash items | 14.31 Million | 152 Thousand | 673 Thousand | -2 Million | 25.59 Million | 4.86 Million |
| Investing Cash Flow | -36.69 Million | 12.41 Million | -129.66 Million | -57.13 Million | -944 Thousand | -8.98 Million |
| Investments in PPE | -508 Thousand | -1.96 Million | -1.71 Million | -1.34 Million | -853 Thousand | -8.98 Million |
| Acquisitions | 36.18 Million | -14.37 Million | 127.95 Million | 55.79 Million | - | - |
| Investment purchases | -194.89 Million | -151.15 Million | -216.23 Million | -124.27 Million | - | - |
| Sales/Maturities of investments | 158.7 Million | 165.52 Million | 88.27 Million | 68.47 Million | - | - |
| Other Investing Activities | -36.18 Million | 14.37 Million | -127.95 Million | -55.79 Million | -91 Thousand | - |
| Financing Cash Flow | 118.12 Million | 84.32 Million | 186.5 Million | 71.13 Million | 64.34 Million | 105.02 Million |
| Debt repayment | - | - | -18 Thousand | -50 Thousand | -45 Thousand | -70 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -193 Thousand | -34 Thousand | - |
| Common Stock Issuance | 118.12 Million | 80.8 Million | 182.85 Million | 69.94 Million | 64.17 Million | 12 Thousand |
| Other Financing Activities | 777 Thousand | 3.51 Million | 3.66 Million | 69.94 Million | 249 Thousand | 105.08 Million |
| Accounts receivables | -308 Thousand | 2.5 Million | -500 Thousand | -2 Million | - | - |
| Accounts payables | -853 Thousand | -1.17 Million | 973 Thousand | 1.77 Million | 803 Thousand | -20 Thousand |
| Inventory | - | - | 1.24 Million | 229 Thousand | - | - |
| Other working capital | -3.45 Million | -4.41 Million | -13.6 Million | 7.5 Million | 10.52 Million | 6.54 Million |
| Cash at beginning of period | 35.09 Million | 36.5 Million | 58.14 Million | 97.8 Million | 73.88 Million | 407 Thousand |
| Cash at end of period | 25.56 Million | 36.19 Million | 36.5 Million | 58.14 Million | 97.8 Million | 73.88 Million |
| Capital Expenditure | -508 Thousand | -1.96 Million | -1.71 Million | -1.34 Million | -853 Thousand | -8.98 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -9.53 Million | -314 Thousand | -21.64 Million | -39.66 Million | 23.91 Million | 73.48 Million |
| Free Cash Flow | -91.47 Million | -99.01 Million | -80.19 Million | -54.99 Million | -40.33 Million | -31.54 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 FY | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 55.4 Million | -26.87 Million | -24.75 Million | -97.33 Million | -24.01 Million | -23.78 Million |
| Depreciation & Amortization | 400 Thousand | 479 Thousand | 508 Thousand | 2.17 Million | 531 Thousand | 567 Thousand |
| Deferred income taxes | - | - | -5.23 Million | -20.3 Million | - | - |
| Stock-based compensation | 4.34 Million | 3.91 Million | 3.44 Million | 14.8 Million | 3.73 Million | 3.36 Million |
| Change in working capital | -96 Thousand | -1.64 Million | -1.03 Million | -4.61 Million | -1.57 Million | 780 Thousand |
| Other non-cash items | 6.61 Million | 2.07 Million | 3.91 Million | 14.31 Million | -1.58 Million | -1.71 Million |
| Investing Cash Flow | -12.5 Million | 38.12 Million | 18.35 Million | -36.69 Million | 19.02 Million | 19.87 Million |
| Investments in PPE | - | -28 Thousand | -77 Thousand | -508 Thousand | -65 Thousand | -195 Thousand |
| Acquisitions | - | - | -18.43 Million | 36.18 Million | 55.04 Million | 74.06 Million |
| Investment purchases | -63.23 Million | -55.81 Million | -25.07 Million | -194.89 Million | -25.98 Million | -17.32 Million |
| Sales/Maturities of investments | 50.73 Million | 93.97 Million | 43.5 Million | 158.7 Million | 45.07 Million | 37.39 Million |
| Other Investing Activities | -12.5 Million | 38.15 Million | 18.43 Million | -36.18 Million | -55.04 Million | -74.06 Million |
| Financing Cash Flow | 377 Thousand | 1.65 Million | 287 Thousand | 118.12 Million | 117.83 Million | 142 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 377 Thousand | 1.65 Million | 287 Thousand | 118.12 Million | - | 142 Thousand |
| Other Financing Activities | 377 Thousand | 1.65 Million | 287 Thousand | 777 Thousand | 117.83 Million | 142 Thousand |
| Accounts receivables | -2.33 Million | 537 Thousand | 43 Thousand | -308 Thousand | 76 Thousand | -557 Thousand |
| Accounts payables | -293 Thousand | 1.1 Million | -817 Thousand | -853 Thousand | -287 Thousand | 163 Thousand |
| Inventory | - | - | 1.00 | - | -76 Thousand | 557 Thousand |
| Other working capital | 2.53 Million | -3.28 Million | -257 Thousand | -3.45 Million | -1.28 Million | 617 Thousand |
| Cash at beginning of period | 39.94 Million | 25.56 Million | 30.08 Million | 35.09 Million | 35.05 Million | 35.82 Million |
| Cash at end of period | 86.7 Million | 39.94 Million | 25.56 Million | 25.56 Million | 31.17 Million | 35.05 Million |
| Capital Expenditure | - | -28 Thousand | -77 Thousand | -508 Thousand | -65 Thousand | -195 Thousand |
| Effect of forex changes on cash | - | - | 119.33 Million | - | -118.96 Million | -364 Thousand |
| Net cash flow / Change in cash | 46.75 Million | 14.38 Million | -4.51 Million | -9.53 Million | -3.88 Million | -768 Thousand |
| Free Cash Flow | 58.89 Million | -25.31 Million | -23.23 Million | -91.47 Million | -22.97 Million | -20.98 Million |
SN
4167
CORT
2181
E25
CDW